Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Cancer|May 6, 2022
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectivenessMelanie Lindenberg, Astrid Kramer, Esther Kok, et al.
Molecular Oncology|December 7, 2023
A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncologyAstrid Kramer, Carmen Rubio-Alarcón, Daan van den Broek, et al.
Pharmacoeconomics|February 7, 2025
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in OncologyAstrid Kramer, Lucas F van Schaik, Daan van den Broek, et al.
Cancers|April 12, 2022
Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical RelevanceSimone N Koole, Daan C L Vessies, Milou M F Schuurbiers, et al.
Therapeutic Advances in Medical Oncology|August 23, 2024
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancerAstrid Kramer, Marjolein J E Greuter, Suzanna J Schraa, et al.
Therapeutic Advances in Medical Oncology|November 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectivenessHaoyue Wang, Astrid Kramer, Marjolein J E Greuter, et al.
The Journal of Molecular Diagnostics : JMD|November 19, 2022
A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical PracticeAstrid Kramer, Ed Schuuring, Daan C L Vessies, et al.
Pageof 1